AR048002A1 - Dispersiones moleculares de drospirenona - Google Patents
Dispersiones moleculares de drospirenonaInfo
- Publication number
- AR048002A1 AR048002A1 ARP050100923A ARP050100923A AR048002A1 AR 048002 A1 AR048002 A1 AR 048002A1 AR P050100923 A ARP050100923 A AR P050100923A AR P050100923 A ARP050100923 A AR P050100923A AR 048002 A1 AR048002 A1 AR 048002A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- drospirenona
- solid
- molecular dispersions
- progestins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04075713 | 2004-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR048002A1 true AR048002A1 (es) | 2006-03-15 |
Family
ID=34928104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050100923A AR048002A1 (es) | 2004-03-10 | 2005-03-10 | Dispersiones moleculares de drospirenona |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN1980636A (sr) |
| AR (1) | AR048002A1 (sr) |
| DE (1) | DE602005022952D1 (sr) |
| GT (1) | GT200500044A (sr) |
| MY (1) | MY143870A (sr) |
| PA (1) | PA8625901A1 (sr) |
| PE (1) | PE20060004A1 (sr) |
| RS (1) | RS50975B (sr) |
| SV (1) | SV2005002043A (sr) |
| TW (2) | TW200609000A (sr) |
| UA (1) | UA90263C2 (sr) |
| UY (1) | UY28802A1 (sr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109420B (zh) * | 2016-08-11 | 2018-07-06 | 吴启旸 | 依普利酮固体分散体及其制剂 |
-
2005
- 2005-03-09 MY MYPI20050960A patent/MY143870A/en unknown
- 2005-03-10 UY UY28802A patent/UY28802A1/es not_active Application Discontinuation
- 2005-03-10 CN CNA2005800150652A patent/CN1980636A/zh active Pending
- 2005-03-10 TW TW094107361A patent/TW200609000A/zh unknown
- 2005-03-10 TW TW097123405A patent/TW200840587A/zh unknown
- 2005-03-10 DE DE602005022952T patent/DE602005022952D1/de not_active Expired - Lifetime
- 2005-03-10 SV SV2005002043A patent/SV2005002043A/es not_active Application Discontinuation
- 2005-03-10 AR ARP050100923A patent/AR048002A1/es unknown
- 2005-03-10 UA UAA200610358A patent/UA90263C2/ru unknown
- 2005-03-10 PE PE2005000278A patent/PE20060004A1/es not_active Application Discontinuation
- 2005-03-10 GT GT200500044A patent/GT200500044A/es unknown
- 2005-03-10 PA PA20058625901A patent/PA8625901A1/es unknown
- 2005-03-10 RS RSP-2009/0307A patent/RS50975B/sr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RS50975B (sr) | 2010-10-31 |
| MY143870A (en) | 2011-07-15 |
| UA90263C2 (en) | 2010-04-26 |
| CN1980636A (zh) | 2007-06-13 |
| PE20060004A1 (es) | 2006-02-16 |
| SV2005002043A (es) | 2005-11-04 |
| PA8625901A1 (es) | 2006-07-03 |
| UY28802A1 (es) | 2005-10-31 |
| GT200500044A (es) | 2005-10-31 |
| TW200609000A (en) | 2006-03-16 |
| DE602005022952D1 (de) | 2010-09-23 |
| TW200840587A (en) | 2008-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hodon et al. | Design and synthesis of pentacyclic triterpene conjugates and their use in medicinal research | |
| CY1109265T1 (el) | Συνθεσεις που συμπεριλαμβανουν δροσπιρενονη μοριακα διασπαρμενη | |
| BRPI0615292A8 (pt) | composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada | |
| GT200500045A (es) | Solidos supersaturados estabilizados de drogas lipofilicas | |
| GT201000095A (es) | Producto de dispersión sólida que contiene un compuesto a base de n-aril urea | |
| GT200600258A (es) | Derivados de n-(piridin-2-il)-sulfonamida | |
| ECSP099030A (es) | Composición farmacéutica que contiene un ácido tetrahidrofólico | |
| CR8717A (es) | Nuevos compuestos | |
| SV2008002527A (es) | Composicion farmaceutica que contiene gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato ref. p-sv-80.273/ug | |
| Fernandez-Llimos et al. | The importance of using standardized terminology in titles and abstracts of pharmacy practice articles | |
| UY29701A1 (es) | Formulaciones líquidas para la administración controlada de derivados de bencisoxazol | |
| GT201000102A (es) | Producto de dispersión sólida de drogas basadas en n-aril urea | |
| BR112014032583A2 (pt) | forma farmacêutica para liberação prolongada de substâncias ativas | |
| Carone et al. | 3D‐Printed Lipid Mesophases for the Treatment of Chronic Liver Disease | |
| AR064104A1 (es) | Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas | |
| AR048002A1 (es) | Dispersiones moleculares de drospirenona | |
| AR055398A1 (es) | Composicion farmaceutica de dispersion solida de pranlukast con mejor tasa de disolucion inicial y metodo para preparar la composicion | |
| CL2012001085A1 (es) | Un producto listo para el consumo gelatinizado a base de agua, jugo, y/o leche que comprende al menos dos masas de gel homogeneas independientes, en el que las masas de gel independientes adyacentes tienen resistencia de gel diferentes. | |
| CL2008002163A1 (es) | Derivados de 2-azetidina y 2-pirrolidina metanoaminas; sus procesos de obtencion; la composicion farmaceutica que los contienen; y sus usos. | |
| BRPI0520568A2 (pt) | uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv | |
| BR112015015485A8 (pt) | composição oleosa de anti-inflamatório, processo de preparação de uma composição e uso de uma composição | |
| UY28370A1 (es) | Agentes terapéuticos | |
| Sayar et al. | Chronic myeloid leukemia within a year of kidney transplant with elevated alkaline phosphatase correlated with imatinib therapy | |
| BRPI0510906A (pt) | composição farmacêutica tópica, composição para administração tópica e seu uso | |
| CA3154077A1 (en) | Microsphere-drug combination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |